The Spanish Cardiovascular Research Center (Centro Nacional de Investigaciones Cardiovasculares Carlos III, commonly referred to as CNIC) today made a commitment in the amount of 5 million euros, which is nearly $6 million USD, to the Mount Sinai School of Medicine. The contribution will be used to fund the Valentin Fuster Laboratories, new research facilities at the Mount Sinai School of Medicine.

"The CNIC's goal is to become a Center of European and international excellence for basic and translational research in cardiovascular disease. A key factor in the CNIC's success will be its relationship with the medical research community around the world," states Valentin Fuster, M.D., Ph.D., Director of both the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Jose and Henry R. Kravis Center for Cardiovascular Health at the Mount Sinai Medical Center, and the Richard Gorlin, MD/Heart Research Foundation Professor. "The CNIC is off to a great start with the new research facilities at the Mount Sinai Medical Center in New York, home of top minds in cardiology today. We look forward to growing the partnership."

The relationship between Dr. Fuster and the CNIC is not a new one. This past June, Spain's Ministry of Health asked Dr. Fuster to lead the research effort at the CNIC. With a strong allegiance to Spain, his homeland, Dr. Fuster took on the role of President of the Scientific Advisory and External Evaluation Committee while maintaining lead research duties at the Mount Sinai Medical Center in New York.

"This is a landmark partnership and the start of a global network for cardiovascular research," shares Dr. Fuster. "We have put into place a highly aggressive scientific interrelation between Mount Sinai and CNIC, as well as with other U.S. and European Centers."

'"/>

Contact: Mount Sinai Press Office
NewsMedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
26-Jan-2006

Page: 1
Related medicine news :

1. DOE commits $27.5M for uranium contaminant transport field studies
2. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
3. Split the difference: Pill-splitting study looks at cost-saving step that could be used by millions
4. FPG receives $8 million for autism research
5. CIRM awards $3.79 million to Burnham Institute
6. The Burroughs Wellcome Fund awards $8 million to infectious disease investigators
7. Scripps Research awarded $17 million for adult stem cell use to treat eye diseases
8. Mayor of New York proposes preventing 100 million deaths from tobacco
9. Menzies School of Health Research receives $5.3 million in Federal Budget
10. $30 million boost to dementia research
11. $1.5 million awarded for palliative care research